Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
about
Role of dupA in virulence of Helicobacter pyloriThe Helicobacter pylori duodenal ulcer promoting gene, dupA in China.Helicobacter pylori and pregnancy-related disorders.Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.Helicobacter pylori CagA: analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor.implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion.Cellular and molecular aspects of gastric cancer.Human infectious diseases and risk of preeclampsia: an updated review of the literature.Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection.Duodenal ulcer promoting gene of Helicobacter pylorithe versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk.Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia.Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.Review article: impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate'.A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model.A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancerEpidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish populationClinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment?Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional studyHelicobacter pylori: host genetics and disease outcomes.Helicobacter pylori in water sources: a global environmental health concern.Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4.Novel Idea: Virulence-Based Therapy Against Helicobacter pylori Infection (Smart Therapy).Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth.Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori.Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infectionAssociation of heterogenicity of Helicobacter pylori cag pathogenicity island with peptic ulcer diseases and gastric cancer.A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis.Association of Vac A- and Cag A-specific Helicobacter pylori strain infection with spontaneous preterm birth.The importance of interleukin 1beta in Helicobacter pylori associated disease.Helicobacter pylori associated antigastric autoantibodies: role in Sjögren's syndrome gastritis.No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease.cag pathogenicity island of Helicobacter pylori in Korean children.Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy.Stool antigen assay to screen H. pylori infection and to assess the success of 3-Day and 7-Day eradication therapy in the patients with partial gastrectomy.Increased frequency of antral CD4 T and CD19 B cells in patients with Helicobacter pylori-related peptic ulcer disease.Nepalese Helicobacter pylori Genotypes Reflects a Geographical Diversity than a True Virulence Factor
P2860
Q28076864-70C8875B-7DF9-497A-B391-3C1B5802CBBBQ33379280-FB0A43FD-2A29-4977-AE6E-F35F933F65C0Q33413540-539B1AD5-7B60-4B12-9E91-56CDBBC9C53FQ33866332-93DB8022-1CE9-4157-A62E-A40BF1D6A361Q33955737-E83BCC97-20D7-4E98-A521-93CD5604CAB0Q34006398-FEAF2D2F-6CAB-4155-99FB-1A793EA3E8C4Q34012910-FEE0E2C1-682A-41E4-8EEF-ACFA2FCA5997Q34557501-7926D3A0-C4AB-472A-9094-05AA17680BA4Q34932961-740A315D-9D5E-4FBB-8152-6C080FE544AAQ35087438-3BA5F655-B8FC-47A7-9F19-9D086DD8A70EQ35506793-6BE4A656-F689-4454-8125-1FE5AEAB6951Q35586754-BC80C42C-8317-459C-A68A-5C9935568693Q35627269-84713634-0F71-498D-853A-72D740F9D0E2Q35630049-546B9E63-D212-4629-8A15-B83FC6D1E4D2Q35886607-90F2E68E-BA47-464B-A25F-4FC8B20F61F4Q36066067-4043DE7B-4A50-445E-8F56-7A08A0EB0314Q36117678-1600E8C9-5078-4AFD-B291-CA96229589F1Q36190752-23837893-8019-4904-BA91-F854B10257D9Q36470495-E802A4F7-E34A-4FE1-BD37-EF84FD176A53Q37189362-16FA40E3-BAAC-49E4-9D14-991970AAB6F4Q37345968-E68946C5-F154-433A-9231-E6B847AD3F36Q37498816-D8DD1B59-25E8-4A9E-949C-87FAAC0F2AE7Q37582815-B8A5317F-BD45-4985-BCC1-1C693D275F00Q38364233-2E0AB683-4C42-4811-9B91-0E17E1A179BEQ38804414-53A9F445-5F4E-4526-87BB-6A0108067D6DQ39421743-2013C92D-863B-489B-BA88-3D9903FF8F71Q39664365-1E9E7AEB-E245-4988-A4F3-EB9D038A1FDCQ39748465-E8645A7F-0DE1-4C97-8438-CC90060F1876Q40188928-E68090B7-F37A-41EC-A885-5BCA29D62FCAQ40638706-6E0CC611-C220-4DE1-869B-D87B7228D9B7Q40651271-CAC2D29F-F852-48D8-9E15-385744964A9EQ43085902-69851740-7673-4A01-A59C-6473535091B3Q43743183-BA95F5EB-A153-4DB0-B955-67BCF60D8F33Q43995239-BF86B7F1-8CA2-4145-9D7C-B9215355F595Q44091804-DD7AC0EA-2B20-44C6-BCAB-BE4207A736B0Q44091807-3A7F40FE-38BD-4C7C-A7D1-0B7D307E6314Q44299622-52A81DC6-9171-4EFE-B7EC-932C5053D2D6Q45038579-D11BA7EF-073B-49AF-ABC5-481C1A0077C3Q45219702-7FCD7212-C059-433A-9782-8B9A92C2D01EQ47715521-7CB82240-9A58-4274-998B-ED740EA2AEB2
P2860
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@ast
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@en
type
label
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@ast
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@en
prefLabel
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@ast
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@en
P2860
P1433
P1476
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise.
@en
P2093
P2860
P304
S3-9; discussion S27-31
P356
10.1046/J.1523-5378.2000.0050S1003.X
P478
P577
2000-01-01T00:00:00Z